Study Group: Oncology Reimbursement Experts (US)
Council Members in this Study Group: 112
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- Richard Tarplin
Principal
Tarplin Strategies, LLC
Richard Tarplin is the founder of Tarplin Strategies in Washington, DC, where he provides strategic advice and lobbying services to clients in the financial services and health care sectors. He served for almost 20 years in the US House of Representatives...
- Bruce Goldberg
President
Pharmacy Benefit AdvisorsBruce Goldberg is the President of Pharmacy Express Services and Pharmacy Benefit Advisors, both based in Omaha, Nebraska. He is a pharmacist and has experience in managed care with PBM contracting and general pharmacy network management. He developed...
- Carrie Harris-Muller
Chief Administrative Officer
KAISER FOUNDATION HOSPITALS INCCarrie Harris-Muller is the Chief Administrative Officer of Kaiser Permanente in the Mid-Atlantic States. Previously, Ms. Harris-Muller served as the Regional Vice President of HealthPlan Administration and Contracting. She has held several executive...
Taral PatelOncologist
MID-OHIO ONCOLOGY & HEMOTOLOGY INCTaral Patel, MD, is an Oncologist in private practice with Mid Ohio Oncology-Hematology, Inc. He treats patients with both cancer and blood disorders. Dr. Patel has been a principal investigator for multiple clinical trials in colon cancer, lung cancer,...
David ZimmermanPresident/Owner
Doctors of Pharmacy, Inc.David Zimmerman, PharmD, FASCP, is the President and an Independent Consultant of Doctors of Pharmacy. Dr. Zimmerman formerly served as the Director of Clinical Affairs at Employee Health Insurance Management, a pharmacy benefit manager. He has over 30...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Tamper Proof Narcotic Pain pill? YES
November 13, 2008
Analysis by: David Zimmerman, President/Owner,FDA Asks if Pain Pill Is Tamper-Proof | online.wsj.com
This drug will allow patients in severe pain to get the necessary pain relief and not have to worry about the other patients that abuse the drug.
-
TREANDA for CLL could be a winner
May 19, 2008
Analysis by: Brian Abbott, Medical Director of Hematology,FDA Accepts TREANDA(R) New Drug Application for the Treatment of Relapsed Indolent Non-Hodgkin's Lymphoma | www.pipelinereview.com
The ease of use compared to fludarabine regimens, and the superior efficacy vs chlorambucil, puts TREANDA in the sweet spot for potential front-line use in CLL.
-
National healthcare? Better find a new pool of physicians
May 19, 2008
Analysis by: Brian Abbott, Medical Director of Hematology,Look to England's example for ways to solve America's health-care problem | www.sltrib.com
National healthcare has again become part of the presidential election dialog, after a curious 12+ year absence. Also curious, Hillary Clinton is again center stage in the discussion. Will the outcome be different this time?
-
Medicare: heading toward a crisis
May 19, 2008
Analysis by: Brian Abbott, Medical Director of Hematology,Loss of Doctors Leaves Patients Waiting | www.redorbit.com
The aging population, coupled with per capita decreases in Medicare spending, threatens the entire health care system. Here's why.
-
Reverse Payments for PHRMA smell fishy
May 15, 2008
Analysis by: Bruce Goldberg, President,US trade agency wants to end deals delaying generics | www.reuters.com
Our FTC has gone on record once again stating that the so called "Phrma reverse payments" to generic manufacturers breach antitrust regulations. Delaying competition by simply paying off another supplier, leads to higher prices for me, you, and our families. My grandpa used to call this stuff by another term....."shmearing".
Members in this Study Group include these company types:
- Office Based Private Practice or Clinic
- Consultancy, Pharma-Focused
- Consultancy, Healthcare-Focused
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Individual/Small Consultancy
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- President
- Owner
- Principal
- Chief Executive Officer
- Physician - Director
- Consultant
- Director
- Medical Director
- Partner
Related Study Groups
| Study Group Name | No. Members |
|---|---|
| Economic Experts on Managed Care | 714 |
| Oncologists (US) | 2241 |
| Generic Drug Economic Experts | 766 |
| Managed Care Experts | 669 |
| Oncologists who Treat Hematologic Malignancies (US) | 855 |
| Hematologists (US) | 994 |
| Hematologists and Oncologists in Private Practice (US) | 462 |
| Aloxi Prescribers for CINV: Oncologists (US) | 47 |
GLG Live Meetings with this Study Group's Leading Experts (?)
July 31, 2007 | Boston
GLGi: Managed Care FormularyJuly 30, 2007 | New York
GLGi: Managed Care FormularyGLG Webcasts & Teleconferences
Leading Experts in Oncology Reimbursement Experts (US) have not participated in any GLG webcasts.